Davis Select U.S. Equity ETF (NASDAQ:DUSA) Shares Acquired by OLD Mission Capital LLC

OLD Mission Capital LLC raised its holdings in shares of Davis Select U.S. Equity ETF (NASDAQ:DUSAGet Rating) by 38.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,164 shares of the healthcare company’s stock after acquiring an additional 6,381 shares during the quarter. OLD Mission Capital LLC owned approximately 0.20% of Davis Select U.S. Equity ETF worth $634,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in DUSA. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Davis Select U.S. Equity ETF in the 1st quarter valued at about $77,000. Geneos Wealth Management Inc. lifted its holdings in shares of Davis Select U.S. Equity ETF by 36.5% in the 2nd quarter. Geneos Wealth Management Inc. now owns 9,341 shares of the healthcare company’s stock valued at $257,000 after purchasing an additional 2,500 shares during the last quarter. Melone Private Wealth LLC purchased a new stake in shares of Davis Select U.S. Equity ETF in the 1st quarter valued at about $353,000. Advisor Group Holdings Inc. lifted its holdings in shares of Davis Select U.S. Equity ETF by 14.0% in the 1st quarter. Advisor Group Holdings Inc. now owns 13,389 shares of the healthcare company’s stock valued at $442,000 after purchasing an additional 1,640 shares during the last quarter. Finally, J.W. Cole Advisors Inc. lifted its holdings in shares of Davis Select U.S. Equity ETF by 26.5% in the 1st quarter. J.W. Cole Advisors Inc. now owns 14,859 shares of the healthcare company’s stock valued at $490,000 after purchasing an additional 3,115 shares during the last quarter.

Davis Select U.S. Equity ETF Price Performance

Davis Select U.S. Equity ETF stock opened at $26.75 on Tuesday. The stock has a 50-day simple moving average of $26.62 and a 200-day simple moving average of $28.07. Davis Select U.S. Equity ETF has a fifty-two week low of $24.67 and a fifty-two week high of $36.42.

Davis Select U.S. Equity ETF Company Profile

(Get Rating)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

See Also

Institutional Ownership by Quarter for Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.